全文获取类型
收费全文 | 9806篇 |
免费 | 1108篇 |
国内免费 | 550篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 33篇 |
妇产科学 | 309篇 |
基础医学 | 1818篇 |
口腔科学 | 35篇 |
临床医学 | 601篇 |
内科学 | 1904篇 |
皮肤病学 | 72篇 |
神经病学 | 25篇 |
特种医学 | 278篇 |
外国民族医学 | 19篇 |
外科学 | 1212篇 |
综合类 | 1231篇 |
现状与发展 | 2篇 |
预防医学 | 144篇 |
眼科学 | 40篇 |
药学 | 401篇 |
3篇 | |
中国医学 | 79篇 |
肿瘤学 | 3222篇 |
出版年
2024年 | 38篇 |
2023年 | 234篇 |
2022年 | 501篇 |
2021年 | 674篇 |
2020年 | 480篇 |
2019年 | 456篇 |
2018年 | 367篇 |
2017年 | 411篇 |
2016年 | 540篇 |
2015年 | 525篇 |
2014年 | 775篇 |
2013年 | 597篇 |
2012年 | 508篇 |
2011年 | 493篇 |
2010年 | 408篇 |
2009年 | 390篇 |
2008年 | 411篇 |
2007年 | 454篇 |
2006年 | 420篇 |
2005年 | 382篇 |
2004年 | 285篇 |
2003年 | 266篇 |
2002年 | 246篇 |
2001年 | 178篇 |
2000年 | 160篇 |
1999年 | 133篇 |
1998年 | 150篇 |
1997年 | 143篇 |
1996年 | 115篇 |
1995年 | 108篇 |
1994年 | 95篇 |
1993年 | 71篇 |
1992年 | 54篇 |
1991年 | 63篇 |
1990年 | 41篇 |
1989年 | 45篇 |
1988年 | 41篇 |
1987年 | 31篇 |
1986年 | 27篇 |
1985年 | 25篇 |
1984年 | 17篇 |
1983年 | 26篇 |
1982年 | 12篇 |
1981年 | 20篇 |
1980年 | 20篇 |
1979年 | 9篇 |
1978年 | 7篇 |
1977年 | 6篇 |
1975年 | 2篇 |
1973年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 390 毫秒
111.
XRCC1多态性与非吸烟女性肺腺癌易感性的关系 总被引:3,自引:0,他引:3
背景与目的XRCC1是一种DNA损伤修复基因,其单核苷酸多态性异常是导致DNA修复能力个体差异的重要原因,可能导致个体患肺癌的危险升高。本研究的目的是探讨XRCC1单核苷酸多态性与非吸烟女性肺腺癌易感性的关系。方法采用以医院患者为基础的病例对照研究方法,研究对象包括非吸烟女性肺腺癌患者126例和同期其它肺部疾病对照126例。以聚合酶链反应一限制性片段长度多态性方法分析XRCC1基因Arg399Gln多态性,比较不同基因型与非吸烟女性肺腺癌的关系,并探讨油烟暴露与基因多态交互作用对患癌风险的影响。结果与携带399Arg/Arg基因型者比较,携带399Gln/Gln基因型者患肺腺癌的风险是其8.695倍(95%CI为3.343~22.614)。携带等位基因399Gln又有油烟暴露的个体患肺腺癌的风险明显增高,校正的比值比为5.21(95%CI为1.85~14.70,P〈0.001)。结论XRCC1基因Arg399 Gln多态性可能是非吸烟女性肺腺癌的遗传易感因素。 相似文献
112.
Neoadjuvant chemotherapy with cisplatin, aclacinomycin A, and mitomycin C for cervical adenocarcinoma – a preliminary study 总被引:3,自引:0,他引:3
T. Saito M. Takehara R. Lee T. Fujimoto M. Nishimura R. Tanaka E. Ito K. Adachi & R. Kudo 《International journal of gynecological cancer》2004,14(3):483-490
Between 1989 and 2002, 28 patients with locally advanced cervical adenocarcinoma (bulky IB-IIIB) were recruited for a pilot study aimed at evaluation of the effectiveness of neoadjuvant chemotherapy with cisplatin, aclacinomycin-A, and mitomycin-C (PAM), followed by radical surgery. This regimen was administrated intra-arterially or intravenously. In addition to patients treated with PAM, we retrospectively analyzed the prognoses of 26 patients in stage I and II, who had been treated between 1975 and 1981 with radical surgery with/without radiation therapy. Twenty-eight patients received PAM therapy as neoadjuvant chemotherapy, and 75.0% of the 16 intra-arterially infused patients showed a response, as did 66.7% of the 12 intravenously infused patients. There was a significant difference in the 5-year prognosis of stage II (PAM group, 72.9%; without-PAM group, 36.4%). The results suggest that, as the free space in the parametrium is widened by neoadjuvant chemotherapy with PAM, it is possible that the tumor could be completely resected by radical hysterectomy. Thus, neoadjuvant chemotherapy with PAM is expected to improve the survival rate of patients with advanced cervical adenocarcinoma by the preliminary study. However, the survival rates of stage II with lymph node metastasis in the without-PAM group seem low, and we must also consider that the various technologies to evaluate and treat the cervical adenocarcinomas, e.g. computed tomography, magnetic resonance imaging, and surgical equipments, had improved during 1989-2002 than was the scenario during 1975-1981, and these improvements contributed to better prognosis. A prospective-randomized study is needed to assess the value of this approach compared with standard management. 相似文献
113.
A. Ayhan R. A. Al C. Baykal E. Demirtas K. Yüce & A. Ayhan† 《International journal of gynecological cancer》2004,14(2):279-285
OBJECTIVES: The objective of this study was to compare clinical and pathologic variables and prognosis of FIGO stage IB adenocarcinoma and squamous cell carcinoma of uterine cervix. METHODS: A retrospective review was performed of 521 patients with stage IB squamous cell carcinoma and adenocarcinoma of cervix who treated primarily by type 3 hysterectomy and pelvic and/or para-aortic lymphadenectomy at Hacettepe University Hospitals between 1980 and 1997. RESULTS: Age, tumor size, grade, depth of invasion, lymph node metastasis, parametrial, vaginal, and lymphvascular space involvement (LVSI) were not different between two cell types except number of the lymph nodes involved. Metastasis to three or more lymph nodes was significantly higher in adenocarcinoma. Overall and disease-free survival were 87.7%, 84.0% versus 86.4%, 83.1% for squamous cell carcinoma and adenocarcinoma, respectively (P > 0.05). The rate and site of recurrence were not different between two cell types. Multivariate analysis of disease-free and overall survival revealed independent prognostic factors as tumor size, LVSI, number of involved lymph node, and vaginal involvement. CONCLUSION: Prognosis of FIGO stage IB cervical cancer patients who were treated by primarily radical surgery was found to be same for those with adenocarcinoma and squamous cell carcinoma. 相似文献
114.
Effect of HIF-1α on VEGF-C Induced Lymphangiogenesis and Lymph Nodes Metastases of Pancreatic Cancer 总被引:4,自引:0,他引:4
The effect of hypoxia inducible factor-1α(HIF-1α) on vascular endothelial growth factor C (VEGF-C) and the correlation between HIF-1αand lymphangiogenesis and lymph nodes metasta-ses (LNM) in pancreatic cancer were investigated. Immunohistochemical SP method was used to detect the protein expression of HIF-1αand VEGF-C, and Lymphatic vessel density (LVD) was determined by stain of VEGFR-3, collagen type IV in 75 pancreatic head cancers from regional pancre-atectomy (RP) during Dec. 2001 to Dec. 2003. The relationship between HIF-1αand VEGF-C, lymphangiogenesis, LNM was analyzed statistically. The results showed that the positive expression rate of HIF-1αand VEGF-C in pancreatic cancer tissues was 48.00 % (36/75) and 65.33 % (49/75) respectively. In positive group of HIF-1α, the positive rate of VEGF-C and LVD, and LVD rate was 80.56 % (29/36), 13.22±3.76 and 88.89 % (32/36) respectively, and in negative group of HEF-1α, positive rate of VEGF-C and LVD was 51.28 % (20/39), 5.98±2.17 and 66.67 % (26/39) respectively (P<0.01 or P<0.05). It was suggested that HIF-1αcould promote the expression of VEGF-C, lymphangiogenesis and LNM in pancreatic cancer. 相似文献
115.
M.TAWFIK EL-MANSI & A.R.W. WILLIAMS 《International journal of gynecological cancer》2006,16(3):1254-1260
PTEN, a tumor suppressor gene, appears to negatively control the phosphoinositide 3-kinase signaling pathway for regulation of cell proliferation and cell survival. Somatic PTEN mutations are involved in a variety of tumors, including endometrial carcinomas, where PTEN expression is diminished. We examined expression of PTEN in a series of cervical adenocarcinomas and precursors, using tissue microarray (TMA) technology. TMA blocks were constructed using paraffin-embedded, formalin-fixed tissues from 273 samples derived from 16 normal cervical biopsies, 119 cases of invasive adenocarcinoma, and 20 high-grade cervical glandular intraepithelial neoplasia (CGIN). Fresh 3-mum sections were cut and immunostained with PTEN, and expression was correlated with clinicopathologic variables, including histologic subtypes of adenocarcinoma. In 137 patients, PTEN expression was positive in 121 (88%). The intensity and distribution of PTEN staining in the tumor tissue were more heterogeneous than those observed in the normal tissues. There were no significant differences in distribution or intensity of PTEN expression between adenocarcinoma in situ and subtypes of invasive adenocarcinoma. Our findings show that unlike the case in most endometrial carcinomas, PTEN expression is retained during the process of carcinogenesis in the glandular cervix. There is, however, evidence of altered distribution and intensity of PTEN expression in cervical adenocarcinoma cells. 相似文献
116.
K.BM. LEE J.M. LEE† C.Y. PARK K.B. LEE H.Y. CHO‡ & S.Y. HA‡ 《International journal of gynecological cancer》2006,16(4):1569-1573
The objective of this study was to investigate the efficacy of treatment strategies in patients with adenocarcinoma (AC) of the cervix and compare it with those with squamous cell carcinoma (SCC) of the cervix. Women with FIGO (1994) stage IB1 AC, especially pathologic tumor size of 2-4 cm, treated with class III hysterectomy, were compared with those with SCC treated with comparable strategy in a case-controlled study. Eighty patients (20 cases, 60 controls) were analyzed. Lymphvascular space invasion (P = 0.01) and lymph node metastasis (P = 0.07) were more frequent in patients with SCC than in those with AC. However, there was no significant difference in depth of stromal invasion (P = 0.51) and invasion of the parametrium (P = 0.44) between two groups. And there was also no statistically significant difference in disease-free survival (P = 0.86) and overall survival (P = 0.89) between two groups. Primary radical surgery followed by adjuvant therapy, same as for SCC, would be acceptable for AC with pathologic tumor size of 2-4 cm. Although it was difficult to determine whether AC recurred more systemically, more effective treatment strategies than those currently available for AC should be considered to reduce the systemic recurrence. 相似文献
117.
I. KALOGIANNIDIS S. LAMBRECHTS F. AMANT P. NEVEN E. VAN LIMBERGEN† & I. VERGOTE 《International journal of gynecological cancer》2006,16(5):1885-1893
Two hundred and eight patients with a clinical stage I endometrial carcinoma were studied (164 fulfilled the inclusion criteria). High risk was defined as nonendometrioid, or endometrioid tumors grade 3 (G3), or G2 with any or G1 with deep (>1/2) myometrial infiltration. The low-risk group consisted of the remaining patients. Surgical staging in the high-risk group included pelvic lymphadenectomy with para-aortic lymphadenectomy in selected cases. Twelve percent of the high-risk patients had nodal metastasis. Patients with low-risk (group A, n = 85) and high-risk disease confined to the uterus (group B, n = 57) did not receive adjuvant radiotherapy. Patients with nodal metastases (group C, n = 10) received postoperative irradiation. The total recurrence rate of the entire population was 12.5%, and the actuarial overall survival, disease-specific survival, and disease-free survival were 90%, 94%, and 88%, respectively. All patients with only vaginal relapse (n = 9) were cured locally with salvage radiotherapy until the date of analysis. The pelvic relapse rate was low as only one patient of group B recurred in the pelvis. In conclusion, lymphadenectomy remains indicated to better select patients at high risk of pelvic recurrence that may benefit from postoperative radiotherapy. 相似文献
118.
119.
目的 建立氯氨顺铂诱导肺腺癌耐药细胞株A549/CDDP。分析A549/CDDP生物学特性及染色体核型,为肺腺癌的治疗提供实验依据。方法 采用氯氨顺铂(Cis—diaminodichloroplatin,CDDP)大剂量冲击加逐步诱导法建立肺腺癌耐药细胞株A549/CDDP,MTT法检测细胞耐药指数.生物发光法测定细胞能量代谢,流式细胞仪测试细胞周期,染色体G显带技术和光谱核型分析(spectral karyotyping,SKY)技术分析染色体变化。结果 MTT检测结果表明。A549/CDDP对7种不同的化疗药物表现了不同的耐药性,其ATP、ADP、AMP含量显著降低,细胞周期无明显变化。G显带结果表明A549/CDDP染色体为亚三倍体,SKY分析出现数条衍生染色体。结论 CDDP可以成功诱导肺腺癌耐药细胞株A549/CDDP,A549/CDDP衍生染色体可能与肺腺癌耐药有关。 相似文献
120.
患者女,52岁。因间断性右下腹疼痛1个月余入院。查体:腹部平坦,右下腹部压痛明显,无反跳痛,腹肌软,右肋缘下腋前线水平可触及约5cm×5cm×3cm大小肿块,边界清楚,活动度可,无触痛。肠镜提示回盲部肿块,肠镜下取肿块组织送病检,报告为回盲部腺癌。腹部B超提示右肝前腹壁深层可见多个大小不等低回声光团,周边轮廓清晰,深吸气时不随肝脏移动。CT检查发现肝脏前下方见5.2cm×4.9cm、3.4cm×1.9cm和6cm×1.7cm边缘清楚光滑的肿块,与肝脏分界清楚,肝脏受压,肝脏大小、形态正常,轮廓规则,各叶比例适中;增强可见肝脏前下肿块明显不均匀强化,腹壁下… 相似文献